Cargando…

Immune Landscape of Breast Cancers

Breast cancer is a very heterogeneous disease, both at a molecular and a histological level. Five intrinsic subtypes were initially identified—Luminal-A, Luminal-B, HER2(+), Triple negative/basal like (TNBC) and normal like—subsequently expanded to seven (Basal-like-1 and 2, mesenchymal, mesenchymal...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagarajan, Divya, McArdle, Stephanie E. B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874677/
https://www.ncbi.nlm.nih.gov/pubmed/29439457
http://dx.doi.org/10.3390/biomedicines6010020
_version_ 1783310206648713216
author Nagarajan, Divya
McArdle, Stephanie E. B.
author_facet Nagarajan, Divya
McArdle, Stephanie E. B.
author_sort Nagarajan, Divya
collection PubMed
description Breast cancer is a very heterogeneous disease, both at a molecular and a histological level. Five intrinsic subtypes were initially identified—Luminal-A, Luminal-B, HER2(+), Triple negative/basal like (TNBC) and normal like—subsequently expanded to seven (Basal-like-1 and 2, mesenchymal, mesenchymal stem-like, luminal androgen receptor, immuno-modulatory and unstable). Although genetic and epigenetic changes are key pathogenic events, the immune system plays a substantial role in promoting progression and metastasis. This review will discuss the extent to which immune cells can be detected within the tumor microenvironment, as well as their prognostic role and relationship with the microbiome, with an emphasis on TNBC.
format Online
Article
Text
id pubmed-5874677
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-58746772018-03-29 Immune Landscape of Breast Cancers Nagarajan, Divya McArdle, Stephanie E. B. Biomedicines Review Breast cancer is a very heterogeneous disease, both at a molecular and a histological level. Five intrinsic subtypes were initially identified—Luminal-A, Luminal-B, HER2(+), Triple negative/basal like (TNBC) and normal like—subsequently expanded to seven (Basal-like-1 and 2, mesenchymal, mesenchymal stem-like, luminal androgen receptor, immuno-modulatory and unstable). Although genetic and epigenetic changes are key pathogenic events, the immune system plays a substantial role in promoting progression and metastasis. This review will discuss the extent to which immune cells can be detected within the tumor microenvironment, as well as their prognostic role and relationship with the microbiome, with an emphasis on TNBC. MDPI 2018-02-11 /pmc/articles/PMC5874677/ /pubmed/29439457 http://dx.doi.org/10.3390/biomedicines6010020 Text en © 2018 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Nagarajan, Divya
McArdle, Stephanie E. B.
Immune Landscape of Breast Cancers
title Immune Landscape of Breast Cancers
title_full Immune Landscape of Breast Cancers
title_fullStr Immune Landscape of Breast Cancers
title_full_unstemmed Immune Landscape of Breast Cancers
title_short Immune Landscape of Breast Cancers
title_sort immune landscape of breast cancers
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5874677/
https://www.ncbi.nlm.nih.gov/pubmed/29439457
http://dx.doi.org/10.3390/biomedicines6010020
work_keys_str_mv AT nagarajandivya immunelandscapeofbreastcancers
AT mcardlestephanieeb immunelandscapeofbreastcancers